Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Pogliani

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|April 7, 1999
The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid MetaplasiaG Barosi, A Ambrosetti, C Finelli, et al.
British Journal of Haematology|April 7, 1999
Induction-consolidation with an idarubicin-containing regimen, unpurged marrow autograft, and post-graft chemotherapy in adult acute lymphoblastic leukaemiaR Bassan, T Lerede, E Di Bona, et al.
Haematologica|December 10, 1999
Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical studyR Bassan, E Pogliani, T Lerede, et al.
Blood Cells, Molecules & Diseases|March 28, 1998
Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosisC Gambacorti-Passerini, P le Coutre, L Mologni, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
Clinical sensitivity to anthracyclines in PH/BCR+ acute lymphoblastic leukemiaR Bassan, A Z Rohatiner, A Rambaldi, et al.
British Journal of Haematology|September 1, 2001
Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphomaS Cortelazzo, A Rambaldi, A Rossi, et al.
Leukemia|September 10, 2011
Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effectA Dodero, F Spina, F Narni, et al.
Blood|June 20, 1998
Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid MetaplasiaG Barosi, A Ambrosetti, A Centra, et al.
Journal of the National Cancer Institute|October 19, 2000
Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571C Gambacorti-Passerini, R Barni, P le Coutre, et al.
Leukemia & Lymphoma|May 1, 1996
Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemiaA Rambaldi, V Attuati, R Bassan, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|April 7, 1999
The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid MetaplasiaG Barosi, A Ambrosetti, C Finelli, et al.
British Journal of Haematology|April 7, 1999
Induction-consolidation with an idarubicin-containing regimen, unpurged marrow autograft, and post-graft chemotherapy in adult acute lymphoblastic leukaemiaR Bassan, T Lerede, E Di Bona, et al.
Haematologica|December 10, 1999
Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical studyR Bassan, E Pogliani, T Lerede, et al.
Blood Cells, Molecules & Diseases|March 28, 1998
Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosisC Gambacorti-Passerini, P le Coutre, L Mologni, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
Clinical sensitivity to anthracyclines in PH/BCR+ acute lymphoblastic leukemiaR Bassan, A Z Rohatiner, A Rambaldi, et al.
British Journal of Haematology|September 1, 2001
Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphomaS Cortelazzo, A Rambaldi, A Rossi, et al.
Leukemia|September 10, 2011
Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effectA Dodero, F Spina, F Narni, et al.
Blood|June 20, 1998
Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid MetaplasiaG Barosi, A Ambrosetti, A Centra, et al.
Journal of the National Cancer Institute|October 19, 2000
Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571C Gambacorti-Passerini, R Barni, P le Coutre, et al.
Leukemia & Lymphoma|May 1, 1996
Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemiaA Rambaldi, V Attuati, R Bassan, et al.
Pageof 6